A Phase II Trial of Celecoxib in Patients With IPMN.
Phase of Trial: Phase II
Latest Information Update: 03 Mar 2016
At a glance
- Drugs Celecoxib (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 15 Feb 2011 Planned end date changed from 1 Sep 2016 to 1 Sep 2021 as reported by ClinicalTrials.gov.
- 12 Jul 2010 Planned end date changed from 1 Sep 2014 to 1 Sep 2016 as reported by ClinicalTrials.gov.